Loveless Bosten A, Moin Kayvon A, Moshirfar Majid, Olson Tyler V, Hoopes Phillip C
Hoopes Vision Research Center, Hoopes Vision, Draper, UT 84020, USA.
College of Osteopathic Medicine, Rocky Vista University, Ivins, UT 84738, USA.
J Clin Med. 2024 Aug 13;13(16):4760. doi: 10.3390/jcm13164760.
: This study aimed to evaluate the visual outcomes and prognosis after cataract surgery in patients with prior history of Verisyse phakic intraocular lens (pIOL) implantation. : A retrospective cohort study involving 215 Verisyse pIOL implantations and 17 explantations was conducted. The Verisyse pIOL was disenclaved and removed through a superior scleral tunnel incision. Cataract extraction with phacoemulsification was then performed through a temporal clear corneal incision. : An occurrence rate of 7.9% of eyes with cataract formation was found. Both uncorrected (UDVA) and corrected visual acuity (CDVA) three months after cataract surgery were significantly improved (0.24 ± 0.30 vs. 0.73 ± 0.48; < 0.001 and 0.10 ± 0.14 vs. 0.30 ± 0.31; = 0.004, respectively). The UDVA was 20/20 or better in 41% of eyes and 20/40 or better in 65% of eyes. The CDVA was 20/20 or better in 53% of eyes and 20/40 or better in 88% of eyes. The safety and efficacy indices were 1.96 ± 1.68 and 1.60 ± 1.36, respectively. : Various complications including cataracts may develop in these patients. Verisyse pIOLs have a lower incidence of cataract formation and are more likely to lead to age-related cataracts rather than the anterior subcapsular cataracts commonly seen in implantable collamer lens (ICL) patients. Patients with a prior history of Verisyse pIOL can expect to have a good visual prognosis after cataract extraction.
本研究旨在评估既往有Verisyse有晶状体眼人工晶状体(pIOL)植入史的患者白内障手术后的视觉效果和预后。
进行了一项回顾性队列研究,纳入215例Verisyse pIOL植入术和17例取出术。通过上方巩膜隧道切口将Verisyse pIOL分离并取出。然后通过颞侧透明角膜切口进行白内障超声乳化摘除术。
发现白内障形成的发生率为7.9%。白内障手术后3个月的未矫正视力(UDVA)和矫正视力(CDVA)均显著提高(分别为0.24±0.30对0.73±0.48;<0.001和0.10±0.14对0.30±0.31;=0.004)。41%的眼睛UDVA为20/20或更好,65%的眼睛UDVA为20/40或更好。53%的眼睛CDVA为20/20或更好,88%的眼睛CDVA为20/40或更好。安全指数和有效指数分别为1.96±1.68和1.60±1.36。
这些患者可能会出现包括白内障在内的各种并发症。Verisyse pIOL白内障形成的发生率较低,更易导致年龄相关性白内障,而非可植入式胶原晶状体(ICL)患者常见的前囊下白内障。既往有Verisyse pIOL植入史的患者白内障摘除术后有望获得良好的视觉预后。